Norgestimate and Ethinyl Estradiol Tablets-Triphasic Regimen Articles
Barr's profits up 24% to $76M
15 May 2006
Barr 2nd-qtr turnover rockets 79%
16 February 2004
Barr introduces generic Tri-Cyclen
5 January 2004
Showing 1-3 of 3 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
